Jupiter Neurosciences, Inc. (JUNS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Jupiter Neurosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.09x | -126.24x | -37.73x | -36.41x | -11.89x | -28.99x |
| P/B Ratio | -19.28x | 73.82x | -31.11x | -25.26x | -10.06x | -12.93x |
| P/S Ratio | 1620.53x | 0.00x | 0.00x | 773.71x | 81.63x | 42.60x |
| Profitability | ||||||
| Gross Margin | 80.6% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -40873.2% | 0.0% | 0.0% | -1471.4% | -612.4% | -164.4% |
| Net Margin | -39662.8% | 0.0% | 0.0% | -2125.2% | -686.4% | -146.9% |
| EBITDA Margin | -39359.9% | 0.0% | 0.0% | -1807.6% | -640.4% | -145.7% |
| Liquidity | ||||||
| Current Ratio | 0.65x | 2.31x | 0.00x | 0.01x | 0.08x | 0.13x |
| Quick Ratio | 0.63x | 2.31x | 0.00x | 0.01x | 0.08x | 0.13x |
| Leverage | ||||||
| Debt/Equity | -2.90x | 0.05x | -0.39x | -0.27x | -0.13x | -0.03x |
YoY = year-over-year change. Source: FMP..